# FDA Inspection 677941 - Biomat USA, Inc. - June 24, 2010

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a1ab5bc7-d0ef-4fa8-8a9a-e8899c220102
Source feed: FDA_Inspections

> FDA Inspection 677941 for Biomat USA, Inc. on June 24, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 677941
- Company Name: Biomat USA, Inc.
- Inspection Date: 2010-06-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1177924 - 2022-08-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b87783ea-fee2-401f-a1ff-1ea2cd8e090d)
- [FDA Inspection 1057030 - 2018-05-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/61797d61-fd1b-43b4-98fc-334ce2ee0124)
- [FDA Inspection 881284 - 2014-06-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2b182542-a61e-4787-98b2-4d200969d107)
- [FDA Inspection 789152 - 2012-06-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8bcc679f-7b08-405f-91df-940d75b1ce9c)
- [FDA Inspection 602283 - 2009-07-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/93f69df0-ee0a-4cae-a225-a5bdbe39e954)

Company: https://www.keypedia.com/companies/biomat-usa-inc/15429a38-3ef3-4731-8426-2197cf7d5445

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d